Maarten Bosland

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. pmc Is There a Future for Chemoprevention of Prostate Cancer?
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
    Cancer Prev Res (Phila) 9:642-7. 2016
  2. pmc A perspective on the role of estrogen in hormone-induced prostate carcinogenesis
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA Electronic address
    Cancer Lett 334:28-33. 2013
  3. pmc Hormones and prostate carcinogenesis: Androgens and estrogens
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago 840 South Wood Street Room 130 CSN, MC 847 Chicago, IL 60612, USA
    J Carcinog 10:33. 2011
  4. pmc Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence
    Nur Ozten-Kandas
    Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
    J Carcinog 10:27. 2011
  5. pmc Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial
    Maarten C Bosland
    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    JAMA 310:170-8. 2013
  6. pmc Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis
    Maarten C Bosland
    University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann N Y Acad Sci 1089:168-76. 2006
  7. pmc Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells
    Maximo A Benavides
    Department of Pathology, University of Illinois at Chicago, College of Medicine, 840 South Wood Street, Chicago, Illinois 60612, USA
    Anticancer Res 30:1881-5. 2010
  8. pmc L-methionine-induced alterations in molecular signatures in MCF-7 and LNCaP cancer cells
    Maximo A Benavides
    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    J Cancer Res Clin Oncol 137:441-53. 2011
  9. pmc The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience
    Ashokkumar A Patel
    Department of Pathology, Center for Pathology Informatics, Benedum Oncology Informatics Center, University of Pittsburgh, Pittsburgh, PA, USA
    BMC Cancer 5:108. 2005
  10. ncbi request reprint Radiographic determination of tissue thickness in paraffin blocks: application to the construction of tissue microarrays
    Xiangtian Kong
    Department of Pathology, New York University School of Medicine, New York, 10016 NY, USA
    Appl Immunohistochem Mol Morphol 15:108-12. 2007

Research Grants

Collaborators

Detail Information

Publications29

  1. pmc Is There a Future for Chemoprevention of Prostate Cancer?
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
    Cancer Prev Res (Phila) 9:642-7. 2016
    ..New phase III trials should be based on adequate preclinical and phase II studies. Cancer Prev Res; 9(8); 642-7. ©2016 AACR. ..
  2. pmc A perspective on the role of estrogen in hormone-induced prostate carcinogenesis
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA Electronic address
    Cancer Lett 334:28-33. 2013
    ..Convincing proof-of-concept studies are needed to definitively test this concept which, if proven, may lead to clinically feasible chemoprevention approaches interfering with these mechanisms. ..
  3. pmc Hormones and prostate carcinogenesis: Androgens and estrogens
    Maarten C Bosland
    Department of Pathology, University of Illinois at Chicago 840 South Wood Street Room 130 CSN, MC 847 Chicago, IL 60612, USA
    J Carcinog 10:33. 2011
    ..It is likely that hormonal and non-hormonal factors as well as genetic and non-genetic (environmental) factors interact in a highly complex and poorly understood manner to determine the risk of prostate cancer...
  4. pmc Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence
    Nur Ozten-Kandas
    Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
    J Carcinog 10:27. 2011
    ....
  5. pmc Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial
    Maarten C Bosland
    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    JAMA 310:170-8. 2013
    ..Soy consumption has been suggested to reduce risk or recurrence of prostate cancer, but this has not been tested in a randomized trial with prostate cancer as the end point...
  6. pmc Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis
    Maarten C Bosland
    University of Illinois at Chicago, Chicago, IL 60612, USA
    Ann N Y Acad Sci 1089:168-76. 2006
    ....
  7. pmc Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells
    Maximo A Benavides
    Department of Pathology, University of Illinois at Chicago, College of Medicine, 840 South Wood Street, Chicago, Illinois 60612, USA
    Anticancer Res 30:1881-5. 2010
    ..Methionine inhibits proliferation of breast and prostate cancer cells. This study aimed to determine cell cycle effects of methionine and selectivity for cancer cells...
  8. pmc L-methionine-induced alterations in molecular signatures in MCF-7 and LNCaP cancer cells
    Maximo A Benavides
    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    J Cancer Res Clin Oncol 137:441-53. 2011
    ..Methionine inhibits proliferation of breast and prostate cancer cells. Here, we determined the influence of L-methionine on functional molecular signatures in these cell lines...
  9. pmc The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience
    Ashokkumar A Patel
    Department of Pathology, Center for Pathology Informatics, Benedum Oncology Informatics Center, University of Pittsburgh, Pittsburgh, PA, USA
    BMC Cancer 5:108. 2005
    ..To facilitate this effort, it was critical to arrive at agreed upon common data elements (CDEs) that could be used to collect demographic, pathologic, treatment and clinical outcome data...
  10. ncbi request reprint Radiographic determination of tissue thickness in paraffin blocks: application to the construction of tissue microarrays
    Xiangtian Kong
    Department of Pathology, New York University School of Medicine, New York, 10016 NY, USA
    Appl Immunohistochem Mol Morphol 15:108-12. 2007
    ..Prior knowledge of tissue thickness in TMA construction can prompt compensatory steps that can enhance the yield of valuable samples and assure sufficient numbers of adequate cores for statistical analysis in biomarker evaluations...
  11. pmc Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations
    Nur Ozten Kandaş
    Department of Pathology, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL 60612, USA
    Nutr Cancer 61:251-64. 2009
    ....
  12. pmc Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate
    David L McCormick
    Life Sciences Research, IIT Research Institute, 10 West 35th Street, Chicago, IL 60616, USA
    Cancer Prev Res (Phila) 3:381-92. 2010
    ....
  13. ncbi request reprint Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat
    David L McCormick
    Life Sciences Group, IIT Research Institute, Chicago, IL 60616, USA
    Nutr Cancer 57:194-200. 2007
    ..Reducing mean body weight by up to 25% through chronic dietary restriction has no effect on the induction of prostate cancers in the Wistar-Unilever rat model...
  14. pmc Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model
    Nur Ozten
    Department of Pathology, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL 60612, USA
    Cancer Prev Res (Phila) 3:371-80. 2010
    ..Importantly, the results of the current animal studies and those reported previously were fully predictive of the outcome of the Selenium and Vitamin E Cancer Prevention Trial...
  15. ncbi request reprint Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor
    David L McCormick
    Life Sciences Group, IIT Research Institute, Chicago, Illinois 60616, USA
    Nutr Cancer 57:184-93. 2007
    ....
  16. ncbi request reprint Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone
    David L McCormick
    Life Sciences Group, IIT Research Institute Chicago, IL 60616, USA
    Carcinogenesis 28:398-403. 2007
    ..The chemopreventive activity of a non-androgenic DHEA analog suggests that at least a portion of the chemopreventive activity of DHEA in the rat prostate is unrelated to hormonal effects...
  17. ncbi request reprint Evaluation of the adequacy of published studies of low-dose effects of bisphenol A on the rodent prostate for use in human risk assessment
    Harry A Milman
    ToxNetwork com, Rockville, Maryland 20853, USA
    Regul Toxicol Pharmacol 35:338-46. 2002
    ....
  18. ncbi request reprint Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells
    Alpana Tyagi
    Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Prostate 53:211-7. 2002
    ....
  19. pmc Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies
    Toby G Rossman
    The Nelson Institute of Environmental Medicine and Kaplan Comprehensive Cancer Center, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA
    Environ Health Perspect 110:749-52. 2002
    ..It is possible that lung and bladder cancers associated with arsenic in drinking water may also require a carcinogenic partner...
  20. ncbi request reprint Chemoprevention strategies for prostate cancer
    Maarten C Bosland
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    Eur J Cancer Prev 11:S18-27. 2002
    ..Such trials are an essential step in the development of antiprostate cancer chemoprevention agents...
  21. ncbi request reprint Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s)
    Bhagavathi A Narayanan
    Division of Nutritional Carcinogenesis, American Health Foundation, Valhalla, New York 10595, USA
    Clin Cancer Res 9:3503-13. 2003
    ..Moreover, we attempted to demonstrate the expression of genes involved in the downstream events related to cyclooxygenase-2 (COX-2) regulation and apoptosis...
  22. ncbi request reprint Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy
    Connie L Finstad
    United Biomedical Inc, 25 Davids Drive, Hauppauge, NY 11788, USA
    Vaccine 22:1300-13. 2004
    ..The results demonstrate universal responsiveness and long duration of androgen deprivation from three diverse species, and thus vaccine efficacy...
  23. ncbi request reprint The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers
    Jonathan Melamed
    Department of Pathology, New York University School of Medicine, New York, New York 10016, USA
    Clin Cancer Res 10:4614-21. 2004
    ..This communication describes the CPCTR to investigators interested in obtaining prostate cancer tissue samples...
  24. ncbi request reprint Adherence to a low-fat diet in men with prostate cancer
    Lilli B Link
    Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York 10032, USA
    Urology 64:970-5. 2004
    ..To design preventive and therapeutic interventions, it is important to know whether men will adhere to these nutritional recommendations, particularly when motivated by the diagnosis of prostate cancer...
  25. ncbi request reprint Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: results from the cooperative prostate cancer tissue resource
    Milton W Datta
    Departments of Pathology, New York University School of Medicine, New York, New York, USA
    J Urol 173:1546-51. 2005
    ..0 ng/ml). It is currently unclear whether these tumors are different from prostate cancer in patients with high PSA levels (greater than 4.0 ng/ml)...
  26. pmc Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat
    Zhuohua Wang
    Department of Medicinal Chemistry and Pharmacognosy, Univeresity od Illinois at Chicago, Chicago, Illinois 60612 7231
    Endocrinology 149:1366-76. 2008
    ....
  27. ncbi request reprint Soy isoflavone consumption is not associated with increased risk of advanced prostate cancer
    Maarten C Bosland
    Cancer Epidemiol Biomarkers Prev 16:2169; author reply 2169-70. 2007
  28. ncbi request reprint Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence
    Bhagavathi A Narayanan
    Department of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987, USA
    Clin Cancer Res 13:5965-73. 2007
    ..In this study, we determined the combined effect of celecoxib, a COX-2 inhibitor, along with exisulind (sulindac sulfone/Aptosyn) at low doses in prostate cancer...
  29. ncbi request reprint Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer
    Ercole L Cavalieri
    Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198 6805, USA
    Carcinogenesis 23:329-33. 2002
    ....

Research Grants6

  1. HORMONAL INDUCTION ANIMAL MODEL OF PROSTATE CANCER
    Maarten Bosland; Fiscal Year: 2002
    ....
  2. IMPROVING ENVIRONMENTAL QUALITY AND HAZARD CONTAINMENT
    Maarten Bosland; Fiscal Year: 2004
    ..abstract_text> ..
  3. 2003 Hormonal Carcinogenesis Gordon Research Conference
    Maarten Bosland; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  4. PHASE II TRIAL OF SOY PRIOR TO RADICAL PROSTATECTOMY
    Maarten Bosland; Fiscal Year: 2007
    ..This study will yield information about bioavaUability of soy isoflavones to the prostate and about modulation of relevant intermediate en-points in the prostate and serum by short-term soy protein intervention. ..
  5. PREVENTION OF PROSTATIC CARCINOGENESIS BY ANTIOXIDANTS
    Maarten Bosland; Fiscal Year: 2008
    ..The observed effects will be compared with the outcome of the single agent studies of Aims 1 and 2. ..
  6. ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
    Maarten C Bosland; Fiscal Year: 2010
    ....